E-LIB Suche - Ergebnisse für: Joppi, Roberta

1

History of trastuzumab: a case study in health technology r..:

Becchetti, Antonella Giorgia ; Martini, Anna ; Scroccaro, Giovanna.
Frontiers in Pharmacology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

The Expiry of Humira® Market Exclusivity and the Entry of A..:

Moorkens, Evelien ; Godman, Brian ; Huys, Isabelle...
Frontiers in Pharmacology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

3

Food and Drug Administration vs European Medicines Agency: ..:

Joppi, Roberta ; Bertele, Vittorio ; Vannini, Tommaso..
British Journal of Clinical Pharmacology. 86 (2019) 1 - p. 170-174 , 2019

Link: https://doi.org/10.1111/..

4

Disinvestment Activities and Candidates in the Health Techn..:

Polisena, Julie ; Trunk, Gerhard ; Gutierrez-Ibarluzea, Iñaki.
International Journal of Technology Assessment in Health Care. 35 (2019) 3 - p. 189-194 , 2019

Link: https://doi.org/10.1017/..

5

Systemic Measures and Legislative and Organizational Framew..:

Bochenek, Tomasz ; Abilova, Vafa ; Alkan, Ali...
Frontiers in Pharmacology. 8 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

6

Barriers for Access to New Medicines: Searching for the Bal..:

Godman, Brian ; Bucsics, Anna ; Vella Bonanno, Patricia...
Frontiers in Public Health. 6 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

7

A disease looking for innovative drugs: The case of pulmona..:

Joppi, Roberta ; Gerardi, Chiara ; Bertele', Vittorio.
European Journal of Internal Medicine. 55 (2018) - p. 47-51 , 2018

Link: https://doi.org/10.1016/..

8

PP022 New Models Are Needed To Optimize The Management Of N..:

Godman, Brian ; Diogene, Eduardo ; Fürst, Jurij...
International Journal of Technology Assessment in Health Care. 33 (2017) S1 - p. 79-80 , 2017

Link: https://doi.org/10.1017/..

9

Adaptive Pathways: Possible Next Steps for Payers in Prepar..:

Vella Bonanno, Patricia ; Ermisch, Michael ; Godman, Brian...
Frontiers in Pharmacology. 8 (2017) - p. , 2017

Link: https://doi.org/10.3389/..

10

Introduction and Utilization of High Priced HCV Medicines a..:

de Bruijn, Winnie ; Ibáñez, Cristina ; Frisk, Pia...
Frontiers in Pharmacology. 7 (2016) - p. , 2016

Link: https://doi.org/10.3389/..

11

Payers' Views of the Changes Arising through the Possible A..:

Ermisch, Michael ; Bucsics, Anna ; Vella Bonanno, Patricia...
Frontiers in Pharmacology. 7 (2016) - p. , 2016

Link: https://doi.org/10.3389/..

12

Cancer as a risk factor for stroke in atrial fibrillation p..:

Denas, Gentian ; Pengo, Vittorio ; Joppi, Roberta.
Thrombosis Research. 136 (2015) 2 - p. 488 , 2015

Link: https://doi.org/10.1016/..

13

A forecasting model for drug utilization and expenditure in..:

Joppi, Roberta ; Cinconze, Elisa ; Demattè, Luca...
Journal of Pharmaceutical Policy and Practice. 8 (2015) S1 - p. , 2015

Link: https://doi.org/10.1186/..

14

Dabigatran - a continuing exemplar case history demonstrati..:

Godman, Brian ; Malmström, Rickard E. ; Diogene, Eduardo...
Frontiers in Pharmacology. 5 (2014) - p. , 2014

Link: https://doi.org/10.3389/..

15

European and Italian regulation on orphan medicinal product:

Joppi, Roberta
Farmeconomia. Health economics and therapeutic pathways. 14 (2013) 2 - p. 89-98 , 2013

Link: https://doi.org/10.7175/..